Researcher

Markus Covert

Profile

Markus Covert is a systems biologist at Stanford University who leads one of the most ambitious projects in quantitative biology: the construction of complete whole-cell computational models of living organisms. His laboratory completed the first comprehensive whole-cell model of Mycoplasma genitalium, the simplest free-living bacterium, incorporating every known molecular component and interaction in a single computational framework. This model can predict cell behavior from genome sequence alone and has been used to make testable predictions about cell physiology and drug interactions. Covert's approach to whole-cell modeling represents a paradigm shift in how biology and medicine could be done in the future: computational models that accurately simulate cellular behavior could eventually replace many animal experiments, enable rational drug design, and predict side effects. His laboratory uses single-cell experimental approaches combined with machine learning to refine these models. The pharmaceutical and biotech industry is interested in whole-cell modeling for drug target identification, prediction of antibiotic resistance, and optimization of synthetic biology constructs. His work is highly relevant to companies in computational drug discovery, synthetic biology platforms, and systems pharmacology.

Industry Ties